Raimon Puig de la Bellacasa Cazorla, PhD
Assistant Professor
+34932672000
RESEARCH LINES
- Synthesis and biological evaluation of new heterocyclic structures with inhibitory capacity of G protein-coupled receptors (GPCR), tyrosine kinases (TK).
- Receptor Tyrosine Kinases (RTK) for application in Cancer, HIV (AIDS), HCV (Hepatitis) and Myotonic Dystrophy.
MEMBER OF:
School of Engineering
Pharmaceutical Chemistry Group
The research focuses on two main areas: New Drugs in Biomedicine and Health Sciences and Flow Chemistry Processes.
LATEST PROJECTS
PreClinIQS080 (Estudio Preclínico Inicial de IQS080, un candidato a fármaco contra el cáncer de páncreas)
Estudio Preclínico de un potente inhibidor multidiana in vitro dirigido a tirosina quinasas intracelulares implicadas en el cáncer de páncreas
Funding Agency:
Research Group Link:
Pharmaceutical Chemistry Group (GQF)
LINKED NEWS
Doctoral thesis
New Synthetic Methodologies for Tyrosine Kinase Inhibitors in Pancreatic Cancer
05/07/2023
Dr Claudi de Rocafiguera recently defended his doctoral thesis at IQS, in which he established an improved synthesis pathway of pyrido[2,3-d]pyrimidin-7(8H)-ones, identifying a multitarget TKI inhibitor candidate against pancreatic ductal adenocarcinoma.
READ FULL NEW
